TransMedics to Participate in High-Profile Investor Conferences in March 2025
TransMedics to Engage Investors at Key Conferences
TransMedics Group, Inc. (Nasdaq: TMDX), based in Andover, Massachusetts, is a pioneering medical technology company that focuses on enhancing organ transplant therapy for patients facing life-threatening conditions like end-stage heart, lung, and liver failure. The company has recently announced exciting participation in two major investor conferences scheduled for March 2025.
Upcoming Conferences
TransMedics is set to have a robust presence at the following events:
- - TD Cowen 45th Annual Health Care Conference
Time: 11:50 a.m. EST
Location: Boston, Massachusetts
- - Oppenheimer 35th Annual Healthcare MedTech Services Conference
Time: 9:20 a.m. EST
Location: Virtual Presentation
During these conferences, TransMedics' management team will participate in engaging discussions designed to shed light on the company’s innovative technologies and strategic future. Investors and stakeholders are encouraged to tune into the live broadcasts.
Accessing the Presentations
A live webcast, as well as an archived version of the presentations, will be readily accessible through the Investors section of the TransMedics website. Investors can find additional details, including the standard investor presentation, by visiting TransMedics Investors.
About TransMedics Group, Inc.
Founded to meet the critical demand for improved organ transplant technology, TransMedics has established itself as a leader in portable extracorporeal warm perfusion, a method that can significantly extend the viability of donor organs. Their innovative solutions not only preserve organ quality but also help assess organ readiness before transplantation, ultimately aiming to increase the availability of viable donor organs.
TransMedics' commitment to resolving the chronic shortage of suitable donor organs aligns with their mission of saving and enhancing patients' lives through cutting-edge medical advancements.
Contact Information
For more inquiries regarding the company's operations or to arrange discussions during the conferences, please reach out to:
Investor Contact:
Brian Johnston
Laine Morgan
Phone: 332-895-3222
Email: Investors@transmedics.com
In conclusion, TransMedics' involvement in these investor conferences highlights their ongoing commitment to innovation in the medical technology landscape, particularly in organ transplant therapy, and serves as an excellent opportunity for investors to gain insights into their transformative work in this crucial field.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.